Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01196442 · ClinicalTrials.gov registry record · NA

Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer

A NA study of Pain and Peripheral Neuropathy, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT01196442 is a NA study of Pain and Peripheral Neuropathy that has completed, run by Virginia Commonwealth University. The registered enrollment target is 39 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01196442, a NA study of Pain and Peripheral Neuropathy, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy. PURPOSE: This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer.

Interventions

  • OTHER questionnaire administration
  • OTHER electrical stimulation pain therapy

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2010-09
Est. Completion 2013-01
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT01196442

The ClinicalTrials.gov registry entry for NCT01196442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.

NCT01196442 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01196442 about?

NCT01196442 is a clinical study titled "Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer". RATIONALE: Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy. PURPOSE: This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer.

What is the current status of trial NCT01196442?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2010-09. Estimated completion is 2013-01.

What conditions does trial NCT01196442 study?

This clinical trial studies the following conditions: Pain, Peripheral Neuropathy, Neurotoxicity, Cancer-related Problem/Condition.

What interventions are being tested in trial NCT01196442?

The interventions under investigation include: questionnaire administration (OTHER), electrical stimulation pain therapy (OTHER).

Who is sponsoring clinical trial NCT01196442?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01196442 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.